IL17A and inflammatory bowel disease: They produce pro-inflammatory cytokines, including IL-17, TNF-α, and IFN-γ, which drive tissue damage in conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and IBD, where IL-17 is a key pathogenic factor [112–114].